4.5 Article

Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder

Journal

ANNALS OF EMERGENCY MEDICINE
Volume 78, Issue 1, Pages 102-108

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.annemergmed.2021.01.017

Keywords

-

Funding

  1. Health Resources and Services Administration [6 GA1RH334840102]
  2. Advance-CTR Mentored Research Award [U54GM115677]

Ask authors/readers for more resources

Buprenorphine treatment greatly reduces mortality among individuals with opioid use disorder, and EMS professionals can play a critical role in bridging the treatment gap to provide better care for those who experience opioid overdoses.
Treatment with buprenorphine significantly reduces both all-cause and overdose mortality among individuals with opioid use disorder. Offering buprenorphine treatment to individuals who experience a nonfatal opioid overdose represents an opportunity to reduce opioid overdose fatalities. Although some emergency departments (EDs) initiate buprenorphine treatment, many individuals who experience an overdose either refuse transport to the ED or are transported to an ED that does not offer buprenorphine. Emergency medical services (EMS) professionals can help address this treatment gap. In this Concepts article, we describe the federal legal landscape that governs the ability of EMS professionals to administer buprenorphine treatment, and discuss state and local regulatory considerations relevant to this promising and emerging practice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available